T. Smith, K. Hill, B. Foley, J. Detter, and A. Munk, Analysis of the Neurotoxin Complex Genes in Clostridium botulinum A1-A4 and B1 Strains: BoNT/A3, /Ba4 and /B1 Clusters Are Located within Plasmids, PLoS ONE, vol.63, issue.12, p.1271, 2007.
DOI : 10.1371/journal.pone.0001271.t003

M. Popoff, Ecology of Neurotoxigenic Strains of Clostridia, Curr Top Microbiol Immunol, vol.195, pp.1-29, 1995.
DOI : 10.1007/978-3-642-85173-5_1

J. Sobel, Botulism, Clinical Infectious Diseases, vol.178, issue.1, pp.1167-1173, 2005.
DOI : 10.1086/515615

K. Inoue, Y. Fujinaga, T. Watanabe, T. Ohyama, and K. Takeshi, Molecular composition of Clostridium botulinum type A progenitor toxins, Infect Immun, vol.64, pp.1589-1594, 1996.

H. Hines, F. Lebeda, M. Hale, and E. Brueggemann, Characterization of Botulinum Progenitor Toxins by Mass Spectrometry, Applied and Environmental Microbiology, vol.71, issue.8, pp.4478-4486, 2005.
DOI : 10.1128/AEM.71.8.4478-4486.2005

F. Chen, G. Kuziemko, and R. Stevens, Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species, Infect Immun, vol.66, pp.2420-2425, 1998.

B. As, Z. Dickens-f, and . Lj, The action of botulinum toxin on the neuro-muscular junction, J Physiol, vol.109, pp.10-24, 1949.

P. Foran, N. Mohammed, G. Lisk, S. Nagwaney, and G. Lawrence, Evaluation of the Therapeutic Usefulness of Botulinum Neurotoxin B, C1, E, and F Compared with the Long Lasting Type A, Journal of Biological Chemistry, vol.351, issue.2, pp.1363-1371, 2003.
DOI : 10.1046/j.1471-4159.2000.0741979.x

S. Arnon, R. Schechter, T. Inglesby, D. Henderson, and J. Bartlett, Botulinum Toxin as a Biological Weapon, JAMA, vol.285, issue.8, pp.1059-1070, 2001.
DOI : 10.1001/jama.285.8.1059

B. Poulain and Y. Humeau, Le mode d???action des neurotoxines botuliques : aspects pathologiques, cellulaires et mol??culaires, Annales de R??adaptation et de M??decine Physique, vol.46, issue.6, pp.265-275, 2003.
DOI : 10.1016/S0168-6054(03)00114-4

A. Casadevall, E. Dadachova, and L. Pirofski, Passive antibody therapy for infectious diseases, Nature Reviews Microbiology, vol.25, issue.9, pp.695-703, 2004.
DOI : 10.1001/jama.1924.02650420009004

A. Casadevall, Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons, Emerging Infectious Diseases, vol.8, issue.8, pp.833-841, 2002.
DOI : 10.3201/eid0808.010516

URL : https://wwwnc.cdc.gov/eid/article/8/8/pdfs/01-0516.pdf

R. Shapiro, C. Hatheway, and D. Swerdlow, Botulism in the United States: A Clinical and Epidemiologic Review, Annals of Internal Medicine, vol.129, issue.3, pp.221-228, 1998.
DOI : 10.7326/0003-4819-129-3-199808010-00011

Z. Dembek, L. Smith, and J. Rusnak, Botulism: Cause, Effects, Diagnosis, Clinical and Laboratory Identification, and Treatment Modalities, Disaster Medicine and Public Health Preparedness, vol.95, issue.02, pp.122-134, 2007.
DOI : 10.1002/(SICI)1097-4598(199910)22:10<1388::AID-MUS8>3.0.CO;2-3

S. Arnon, Creation and Development of the Public Service Orphan Drug Human Botulism Immune Globulin, PEDIATRICS, vol.119, issue.4, pp.785-789, 2007.
DOI : 10.1542/peds.2006-0646

C. Tacket, W. Shandera, J. Mann, N. Hargrett, and P. Blake, Equine antitoxin use and other factors that predict outcome in type A foodborne botulism, The American Journal of Medicine, vol.76, issue.5, pp.794-798, 1984.
DOI : 10.1016/0002-9343(84)90988-4

R. Black and R. Gunn, Hypersensitivity reactions associated with botulinal antitoxin, The American Journal of Medicine, vol.69, issue.4, pp.567-570, 1980.
DOI : 10.1016/0002-9343(80)90469-6

T. Smith, J. Lou, I. Geren, C. Forsyth, and R. Tsai, Sequence Variation within Botulinum Neurotoxin Serotypes Impacts Antibody Binding and Neutralization, Infection and Immunity, vol.73, issue.9, pp.5450-5457, 2005.
DOI : 10.1128/IAI.73.9.5450-5457.2005

URL : http://iai.asm.org/content/73/9/5450.full.pdf

S. Adekar, T. Takahashi, R. Jones, F. Saleem, and D. Ancharski, Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain, PLoS ONE, vol.304, issue.8, p.3023, 2008.
DOI : 10.1371/journal.pone.0003023.t002

L. Stanker, P. Merrill, M. Scotcher, and L. Cheng, Development and partial characterization of high-affinity monoclonal antibodies for botulinum toxin type A and their use in analysis of milk by sandwich ELISA, Journal of Immunological Methods, vol.336, issue.1, pp.1-8, 2008.
DOI : 10.1016/j.jim.2008.03.003

H. Volland, P. Larnourette, M. Nevers, C. Mazuet, and E. Ezan, A sensitive sandwich enzyme immunoassay for free or complexed Clostridium botulinum neurotoxin type A, Journal of Immunological Methods, vol.330, issue.1-2, pp.120-129, 2008.
DOI : 10.1016/j.jim.2007.11.006

M. Tavallaie, A. Chenal, D. Gillet, Y. Pereira, and M. Manich, Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies, FEBS Letters, vol.23, issue.1-3, pp.299-306, 2004.
DOI : 10.1023/B:JOPC.0000016257.91979.06

M. Mowry, M. Meagher, L. Smith, J. Marks, and A. Subramanian, Production and purification of a chimeric monoclonal antibody against botulinum neurotoxin serotype A, Protein Expression and Purification, vol.37, issue.2, pp.399-408, 2004.
DOI : 10.1016/j.pep.2004.06.022

M. Liang, S. Dubel, D. Li, I. Queitsch, and W. Li, Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments, Journal of Immunological Methods, vol.247, issue.1-2, pp.119-130, 2001.
DOI : 10.1016/S0022-1759(00)00322-7

C. Hatheway, J. Snyder, J. Seals, T. Edell, G. Lewis et al., Antitoxin Levels in Botulism Patients Treated with Trivalent Equine Botulism Antitoxin to Toxin Types A, B, and E, Journal of Infectious Diseases, vol.150, issue.3, pp.407-412, 1984.
DOI : 10.1093/infdis/150.3.407

J. Dokmetjian, V. Della, V. Lavigne, C. De-lujan, and M. Manghi, A possible explanation for the discrepancy between ELISA and neutralising antibodies to tetanus toxin, Vaccine, vol.18, issue.24, pp.2698-2703, 2000.
DOI : 10.1016/S0264-410X(00)00066-9

J. Maynard, C. Maassen, S. Leppla, K. Brasky, and J. Patterson, Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity, Nature Biotechnology, vol.20, issue.6, pp.597-601, 2002.
DOI : 10.1038/nbt0602-597

A. Nowakowski, C. Wang, D. Powers, P. Amersdorfer, and T. Smith, Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody, Proceedings of the National Academy of Sciences, vol.287, issue.5458, pp.11346-11350, 2002.
DOI : 10.1126/science.287.5458.1664

L. Cheng, L. Stanker, T. Henderson, J. Lou, and J. Marks, Antibody Protection against Botulinum Neurotoxin Intoxication in Mice, Infection and Immunity, vol.77, issue.10, pp.4305-4313, 2009.
DOI : 10.1128/IAI.00405-09

URL : http://iai.asm.org/content/77/10/4305.full.pdf

S. Adekar, R. Jones, M. Elias, F. Saleem, and M. Root, Hybridoma populations enriched for affinity-matured human IgGs yield highaffinity antibodies specific for botulinum neurotoxins, J Immunol Methods, vol.20333, pp.156-166, 2008.
DOI : 10.1016/j.jim.2008.01.015

E. Pharmacopoeia, Botulinum antitoxin, 2002.

G. Ellman, A. Burkhalter, and J. Ladou, A fluorometric method for the determination of hippuric acid, J Lab Clin Med, vol.57, pp.813-818, 1961.

M. Shulman, C. Wilde, and G. Kohler, A better cell line for making hybridomas secreting specific antibodies, Nature, vol.3, issue.5685, pp.269-270, 1978.
DOI : 10.1038/266550a0

G. Dighiero, P. Lymberi, J. Mazie, S. Rouyre, and G. Butler-browne, Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens, J Immunol, vol.131, pp.2267-2272, 1983.

R. Horton, H. Hunt, S. Ho, J. Pullen, and L. Pease, Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension, Gene, vol.77, issue.1, pp.61-68, 1989.
DOI : 10.1016/0378-1119(89)90359-4

A. Krebber, S. Bornhauser, J. Burmester, A. Honegger, and J. Willuda, Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system, Journal of Immunological Methods, vol.201, issue.1, pp.35-55, 1997.
DOI : 10.1016/S0022-1759(96)00208-6

D. Boquet, C. Creminon, G. Clement, Y. Frobert, and M. Nevers, Quantitative Measurement of Bitagged Recombinant Proteins Using an Immunometric Assay: Application to an Anti-Substance P Recombinant Antibody, Analytical Biochemistry, vol.284, issue.2, pp.221-230, 2000.
DOI : 10.1006/abio.2000.4711

K. Dee and M. Shuler, Optimization of an Assay for Baculovirus Titer and Design of Regimens for the Synchronous Infection of Insect Cells, Biotechnology Progress, vol.13, issue.1, pp.14-24, 1997.
DOI : 10.1021/bp960086t

S. Hober, K. Nord, and M. Linhult, Protein A chromatography for antibody purification, Journal of Chromatography B, vol.848, issue.1, pp.40-47, 2007.
DOI : 10.1016/j.jchromb.2006.09.030

D. Cleveland, S. Fischer, M. Kirschner, and U. Laemmli, Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis, J Biol Chem, vol.252, pp.1102-1106, 1977.

A. Drake, D. Myszka, and S. Klakamp, Characterizing high-affinity antigen/antibody complexes by kinetic- and equilibrium-based methods, Analytical Biochemistry, vol.328, issue.1, pp.35-43, 2004.
DOI : 10.1016/j.ab.2003.12.025